Skip to content

Increasing demand for PEP in UK, but targets still missed

Number of UK gay men ever tested rises to two-thirds

Gay men often not accessing PEP despite risk of HIV exposure

Raltegravir may have role in PEP if exposure involves drug-resistant HIV

Unsuccessful post-exposure prophylaxis may still result in weaker HIV infection and lower viral load

IAS: Randomised comparison concludes d4T more tolerable than AZT in triple nuke PEP regimen

Uneven PEP awareness amongst people living with HIV in France

Equal access to PEP in UK legal spotlight

CROI: Study reveals widespread misunderstandings about post-exposure prophylaxis among US doctors